Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Octavio Servitje

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Investigative Dermatology|November 19, 2014
MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphomaJuan Sandoval, Angel Díaz-Lagares, Rocío Salgado, et al.
JAMA Dermatology|November 14, 2018
Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With BexaroteneIrene Cabello, Pedro Alia, Xavier Pintó, et al.
The Journal of Investigative Dermatology|April 4, 2016
Identification of Gene Mutations and Fusion Genes in Patients with Sézary SyndromeAparna Prasad, Raquel Rabionet, Blanca Espinet, et al.
Journal of Clinical Laboratory Analysis|December 20, 2023
High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndromeGonzalo Blanco, Daniel López-Aventín, Ramon M Pujol, et al.
The Journal of Investigative Dermatology|August 25, 2015
Notch1 Pathway Activation Results from the Epigenetic Abrogation of Notch-Related MicroRNAs in Mycosis FungoidesFernando Gallardo, Juan Sandoval, Angel Díaz-Lagares, et al.
European Journal of Dermatology : EJD|May 5, 2017
A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designsMartine Bagot, Baktiar Hasan, Sean Whittaker, et al.
Journal of the American Academy of Dermatology|July 20, 2020
Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma RegistryCristina Muniesa, Eva Domingo-Domenech, Rosa Fornons-Servent, et al.
The Journal of Investigative Dermatology|September 17, 2010
Primary cutaneous CD30+ anaplastic large-cell lymphomas show a heterogeneous genomic profile: an oligonucleotide arrayCGH approachJúlia M Sánchez-Schmidt, Rocío Salgado, Octavio Servitje, et al.
The Lancet. Haematology|June 2, 2022
Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trialPablo L Ortiz-Romero, Lidia Maroñas Jiménez, Cristina Muniesa, et al.
The Journal of Investigative Dermatology|September 18, 2009
Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoidesRocío Salgado, Octavio Servitje, Fernando Gallardo, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Investigative Dermatology|November 19, 2014
MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphomaJuan Sandoval, Angel Díaz-Lagares, Rocío Salgado, et al.
JAMA Dermatology|November 14, 2018
Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With BexaroteneIrene Cabello, Pedro Alia, Xavier Pintó, et al.
The Journal of Investigative Dermatology|April 4, 2016
Identification of Gene Mutations and Fusion Genes in Patients with Sézary SyndromeAparna Prasad, Raquel Rabionet, Blanca Espinet, et al.
Journal of Clinical Laboratory Analysis|December 20, 2023
High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndromeGonzalo Blanco, Daniel López-Aventín, Ramon M Pujol, et al.
The Journal of Investigative Dermatology|August 25, 2015
Notch1 Pathway Activation Results from the Epigenetic Abrogation of Notch-Related MicroRNAs in Mycosis FungoidesFernando Gallardo, Juan Sandoval, Angel Díaz-Lagares, et al.
European Journal of Dermatology : EJD|May 5, 2017
A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designsMartine Bagot, Baktiar Hasan, Sean Whittaker, et al.
Journal of the American Academy of Dermatology|July 20, 2020
Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma RegistryCristina Muniesa, Eva Domingo-Domenech, Rosa Fornons-Servent, et al.
The Journal of Investigative Dermatology|September 17, 2010
Primary cutaneous CD30+ anaplastic large-cell lymphomas show a heterogeneous genomic profile: an oligonucleotide arrayCGH approachJúlia M Sánchez-Schmidt, Rocío Salgado, Octavio Servitje, et al.
The Lancet. Haematology|June 2, 2022
Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trialPablo L Ortiz-Romero, Lidia Maroñas Jiménez, Cristina Muniesa, et al.
The Journal of Investigative Dermatology|September 18, 2009
Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoidesRocío Salgado, Octavio Servitje, Fernando Gallardo, et al.
Pageof 5